Gastrointestinal stromal tumors of the stomach

Minerva Chirurgica

Volumn 59, Issue 3, 2004, Pages 219-231

  Matthews, B D ^a   Joels, C S ^a   Kercher, K W ^a   Heniford, B T ^a  

^a CAROLINAS MEDICAL CENTER   (United States)

Author keywords

Gastric mucosa; Gastrointestinal neoplasms, surgery; Laparoscopy; Stomach neoplasms, surgery; Stromal cells

Indexed keywords

IMATINIB; TRABECTEDIN;

ABDOMINAL SCINTISCANNING; CANCER STAGING; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DNA DETERMINATION; DRUG EFFICACY; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL STROMAL TUMOR; GASTROTOMY; HUMAN; IMMUNOHISTOCHEMISTRY; LAPAROSCOPY; LAPAROTOMY; LOWER ESOPHAGUS SPHINCTER; NUCLEAR MAGNETIC RESONANCE IMAGING; PYLORUS; REVIEW; STOMACH WALL;

ESOPHAGOGASTRIC JUNCTION; GASTROINTESTINAL NEOPLASMS; HUMANS; LAPAROSCOPY; LEIOMYOMA; LEIOMYOSARCOMA; NEOPLASM STAGING; PYLORUS; STROMAL CELLS;

EID: 4844220958     PISSN: 00264733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Vanderwinden JM. Role of interstitial cells of Cajal and their relationship with the enteric nervous system. Eur J Morphol 1999;37:250-6.
2. Lee JR, Joshi V, Griffin JW Jr, Lasota J, Miettinen M. Gastrointestinal autonomic nerve tumor: immunohistochemical and molecular identity with gastrointestinal stromal tumor. Am J Surg Pathol 2001;25:979-87.
3. Miettinen M, Sarlomo-Rikala M, Lasota J. Gastrointestinal stromal tumors: recent advances in understanding of their biology. Hum Pathol 1999;30:1213-20.
4. Miettinen M, Sarlomo-Rikala M, Lasota J. Gastrointestinal stromal tumours. Ann Chir Gynaecol 1998;87:278-81.
5. Hasegawa T, Matsuno Y, Shimoda T, Hirohashi S. Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade. Hum Pathol 2002;33:669-76.
6. Pierie JP, Choudry U, Muzikansky A, Yeap BY, Souba WW, Ott MJ. The effect of surgery and grade on outcome of gastrointestinal stromal tumors. Arch Surg 2001;136:383-9.
7. Hedenbro JL, Ekelund M, Wetterberg P. Endoscopic diagnosis of submucosal gastric lesions. The results after routine endoscopy. Surg Endosc 1991;5:20-3.
8. rd, Wertheimer-Hatch L, Hatch KF, Foster RS Jr et al. Tumors of the stomach. World J Surg 2000;24:412-20.
9. Emory TS, Sobin LH, Lukes L, Lee DH, O'Leary TJ. Prognosis of gastrointestinal smooth-muscle (stromal) tumors: dependence on anatomic site. Am J Surg Pathol 1999;23:82-7.
10. Welch JP. Smooth muscle tumors of the stomach. Am J Surg 1975;130:279-85.
11. Golden T, Stout AP. Smooth muscle tumors of the gastrointestinal tract and retroperitoneal tissues. Surg Gynecol Obstet 1941;73:784-810.
12. Kitamura Y, Hirota S, Nishida T. A loss-of-function mutation of c-kit results in depletion of mast cells and interstitial cells of Cajal, while its gain-of-function mutation results in their oncogenesis. Mutat Res 2001;477:165-71.
13. Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998;279:577-80.
14. Sakurai S, Oguni S, Hironaka M, Fukayama M, Morinaga S, Saito K. Mutations in c-kit gene exons 9 and 13 in gastrointestinal stromal tumors among Japanese. Jpn J Cancer Res 2001;92:494-8.
15. Sakurai S, Fukasawa T, Chong JM, Tanaka A, Fukayama M. C-kit gene abnormalities in gastrointestinal stromal tumors (tumors of interstitial cells of Cajal). Jpn J Cancer Res 1999;90:1321-8.
16. Kim NG, Kim JJ, Ahn JY, Seong CM, Noh SH, Kim CB et al. Putative chromosomal deletions on 9P, 9Q and 22Q occur preferentially in malignant gastrointestinal stromal tumors. Int J Cancer 2000;85:633-8.
17. Fukasawa T, Chong JM, Sakurai S, Koshiishi N, Ikeno R, Tanaka A et al. Allelic loss of 14q and 22q, NF2 mutation, and genetic instability occur independently of c-kit mutation in gastrointestinal stromal tumor. Jpn J Cancer Res 2000;91:1241-9.
18. el-Naggar AK, Ro JY, McLemore D, Garnsey L, Ordonez N, MacKay B. Gastrointestinal stromal tumors: DNA flow-cytometric study of 58 patients with at least 5 years of follow-up. Mod Pathol 1989;2:511-5.
19. Ignjatovic M. Gastrointestinal stromal tumors. Vojnosanit Pregl 2002;59:183-202.
20. Sanders L, Silverman M, Rossi R, Eraasch J, Munson L. Gastric smooth muscle tumors: diagnostic dilemmas and factors affecting outcome. World J Surg 1996;20:992-5.
21. Brand B, Oesterhelweg L, Binmoeller KF, Sriram PV, Bohnacker S, Seewald S et al. Impact of endoscopic ultrasound for evaluation of submucosal lesions in gastrointestinal tract. Dig Liver Dis 2002;34:290-7.
22. Chak A, Canto MI, Rosch T, Dittler HJ, Hawes RH, Tio TL et al. Endosonographic differentiation of benign and malignant stromal cell tumors. Gastrointest Endosc 1997;45:468-73.
23. Ando N, Goto H, Niwa Y, Hirooka Y, Ohmiya N, Nagasaka T et al. The diagnosis of GI stromal tumors with EUS-guided fine needle aspiration with immunohistochemical analysis. Gastrointest Endosc 2002;55:37-43.
24. Gu M, Ghafari S, Nguyen PT, Lin F. Cytologic diagnosis of gastrointestinal stromal tumors of the stomach by endoscopic ultrasound-guided fine-needle aspiration biopsy: cytomorphologic and immunohistochemical study of 12 cases. Diagn Cytopathol 2001;25:343-50.
25. Rader AE, Avery A, Wait CL, McGreevey LS, Faigel D, Heinrich MC. Fine-needle aspiration biopsy diagnosis of gastrointestinal stromal tumors using morphology, immunocytochemistry, and mutational analysis of c-kit. Cancer 2001;93:269-75.
26. Pidhorecky I, Cheney RT, Kraybill WG, Gibbs JF. Gastrointestinal stromal tumors: current diagnosis, biologic behavior, and management. Ann Surg Oncol 2000;7:705-12.
27. Padilla C, Saez A, Vidal A, Garcia L, Tolosa F, Andreu FJ et al. Fine-needle aspiration cytology diagnosis of metastatic gastrointestinal stromal tumor in the liver: a report of three cases. Diagn Cytopathol 2002;27:298-302.
28. Hasegawa S, Semelka RC, Noone TC, Woosley JT, Marcos HB, Kenney PJ et al. Gastric stromal sarcomas: correlation of MR imaging and histopathologic findings in 9 patients. Radiology 1998;208:591-5.
29. Wang CK, Kuo YT, Liu GC, Tsai KB, Huang YS. Dynamic contrast-enhanced subtraction and delayed MRI of gastric tumors: radiologic-pathologic correlation. J Comput Assist Tomogr 2000;24:872-7.
30. Van den Abbeele AD, Badawi RD. Use of positron emission tomography in oncology and its potential role to assess response to imatinib mesylate therapy in gastrointestinal stromal tumors (GISTs). Eur J Cancer 2002; 38 Suppl 5:S60-5.
31. van Oosterom AT, Judson I, Verweij J, Stroobants S, Donato di Paola E, Dimitrijevic S et al. Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study. Lancet 2001;358:1421-3.
32. th ed. New York: Springer-Verlag; 2002.p.221-8.
33. Appleman HD, Helwig EB. Gastric epithelioid leiomyoma and leiomyosarcoma (leiomyoblastoma). Cancer 1976;38:708-28.
34. DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 2000;231:51-8.
35. Piso P, Schlitt HJ, Klempnauer J. Stromal sarcoma of the stomach: therapeutic considerations. Eur J Surg 2000;166:954-8.
36. Silas AM, Kruskal JB, Kane RA. Intraoperative ultrasound. Radiol Clin North Am 2001;39:429-48.
37. Ohashi S. Laparoscopic intraluminal (intragastric) surgery for early gastric cancer. A new concept in laparoscopic surgery. Surg Endosc 1995;9:169-71.
38. Heniford BT, Area MJ, Walsh RM. The mini-laparoscopic intragastric resection of a gastroesophageal stromal tumor: a novel approach. Surg Laparosc Endosc Percutan Tech 2000;10:82-5.
39. Matthews BD, Sing RF, DeLegge MH, Ponsky JL, Heniford BT. Initial results with a stapled gastrojejunostomy for the laparoscopic isolated roux-en-Y gastric bypass. Am J Surg 2000;179:476-81.
40. Cuschieri A. Laparoscopic gastric resection. Surg Clin North Am 2000;80:1269-84, viii.
41. Goh PM, Alponat A, Mak K, Kum CK. Early international results of laparoscopic gastrectomies. Surg Endosc 1997;11:650-2.
42. Walsh RM, Heniford BT. Laparoendoscopic treatment of gastric stromal tumors. Semin Laparosc Surg 2001;8:189-94.
43. Shimizu S, Noshiro H, Nagai E, Uchiyama A, Mizumoto K, Tanaka M. Laparoscopic wedge resection of gastric submucosal tumors. Dig Surg 2002;19:169-73.
44. Choi YB, Oh ST. Laparoscopy in the management of gastric submucosal tumors. Surg Endosc 2000;14:741-5.
45. Matthews BD, Walsh RM, Kercher KW, Sing RF, Pratt BL, Answini GA et al. Laparoscopic vs open resection of gastric stromal tumors. Surg Endosc 2002;16:803-7.
46. Tagaya N, Mikami H, Kogure H, Kubota K, Hosoya Y, Nagai H. Laparoscopic intragastric stapled resection of gastric submucosal tumors located near the esophagogastric junction. Surg Endosc 2002;16:177-9.
47. Hepworth CC, Menzies D, Motson RW. Minimally invasive surgery for posterior gastric stromal tumors. Surg Endosc 2000;14:349-53.
48. Otani Y, Ohgami M, Igarashi N, Kimata M, Kubota T, Kumai K et al. Laparoscopic wedge resection of gastric submucosal tumors. Surg Laparosc Endosc Percutan Tech 2000;10:19-23.
49. Trupiano JK, Stewart RE, Misick C, Appelman HD, Goldblum JR. Gastric stromal tumors: a clinicopathologic study of 77 cases with correlation of features with nonaggressive and aggressive clinical behaviors. Am J Surg Pathol 2002;26:705-14.
50. Carson W, Karakousis C, Douglass H, Rao U, Palmer ML. Results of aggressive treatment of gastric sarcoma. Ann Surg Oncol 1994;1:244-51.
51. Ryan DP, Puchalski T, Supko JG, Harmon D, Maki R, Garcia-Carbonero R et al. A phase II and pharmacokinetic study of ecteinascidin 743 in patients with gastrointestinal stromal tumors. Oncologist 2002;7:531-8.
52. Sugarbaker PH. Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis. Semin Surg Oncol 1998;14:254-61.
53. Dougherty MJ, Compton C, Talbert M, Wood WC. Sarcomas of the gastrointestinal tract. Separation into favorable and unfavorable prognostic groups by mitotic count. Ann Surg 1991;214:569-74.
54. DeMatteo RP, Shah A, Fong Y, Jarnagin WR, Blumgart LH, Brennan MF. Results of hepatic resection for sarcoma metastatic to liver. Ann Surg 2001;234:540-7; discussion 547-8.
55. Kim CJ, Day S, Yeh KA. Gastrointestinal stromal tumors: analysis of clinical and pathologic factors. Am Surg 2001;67:135-7.
56. Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002;347:472-80.
57. Cancer Therapy Evaluation Program. Common toxicity criteria manual: common toxicity criteria, version 2.0. Bethesda, MD: National Cancer Institute; 1999.